COMMUNIQUÉS West-GlobeNewswire

Portola Pharmaceuticals to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018
02/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]
Terra Tech Corp. Schedules Second Quarter 2018 Earnings Release for Thursday, August 9, 2018
02/08/2018
IRVINE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]
Viveve to Announce Financial Results for Second Quarter 2018 and Host Conference Call
02/08/2018
ENGLEWOOD, Colo., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, will announce financial results for the second quarter ended June [...]
Voyager Therapeutics to Present at Investor Conferences in August
02/08/2018
CAMBRIDGE, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced [...]
Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea
02/08/2018
IRVINE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) announced today that the Korean Intellectual Property Office (KIPO) has issued a Notice of Allowance for a patent application covering [...]
Genocea Reports Second Quarter 2018 Financial and Operating Results
02/08/2018
Neoantigen vaccine program GEN-009 Phase 1/2a clinical trial underway ATLAS™ platform continues to stand apart from in silico methods of neoantigen identification Conference call today at 9:00 am ET CAMBRIDGE, Mass., [...]
Celldex to Report Second Quarter 2018 Financial Results and Host Corporate Update Call
02/08/2018
HAMPTON, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second quarter 2018 financial results on Wednesday, August 8, 2018 after the U.S. financial markets close. Celldex [...]
CoolSculpting – New Jersey Plastic Surgeon Discusses Popular Non-Surgical Fat Reduction Treatment
02/08/2018
Dr. Christopher P. Godek of The Personal Enhancement Center says CoolSculpting® continues its rise in popularity as one of the most effective non-surgical options for patients looking to reduce excess fat pockets in a [...]
Oncobiologics Appoints Lawrence A. Kenyon as President and CEO
02/08/2018
CRANBURY, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that Lawrence A. Kenyon, its Chief Financial Officer (CFO) and Corporate Secretary, has been appointed to the role of [...]
OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights
02/08/2018
-Company prioritizes its navicixizumab resources in platinum-resistant ovarian cancer; prepares to share data in Q4 of 2018- -Cash runway extended by an additional quarter to YE 2019- REDWOOD CITY, Calif., Aug. 02, 2018 [...]
Celtaxsys Announces Results of Phase 2 Trial Showing Clinically Meaningful Improvement in Pulmonary Exacerbations in Cystic Fibrosis Patients
02/08/2018
-Acebilustat is the first novel anti-inflammatory molecule evidencing the potential to reduce frequency of pulmonary exacerbations and prolong time to first exacerbation in CF patients --Celtaxsys, with continued [...]
Catalyst Biosciences Reports Second Quarter Operating & Financial Results and Provides Corporate Update
02/08/2018
Announced Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) (FVIIa) in Individuals with Hemophilia A or B with Inhibitors Presented CB 2679d (FIX) Phase 1/2 Data at the World Federation of [...]
Alder BioPharmaceuticals® to Present at the Canaccord Genuity 38th Annual Growth Conference
02/08/2018
BOTHELL, Wash., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Caladrius Biosciences to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018 at 4:30 p.m. ET
02/08/2018
BASKING RIDGE, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology platforms targeting [...]
Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
02/08/2018
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will present at the [...]
CASMED Reports Second Quarter 2018 Financial Results
02/08/2018
Achieves 20% U.S. FORE-SIGHT® sales growth, expands gross margin, narrows operating loss Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Aug. 02, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, [...]
Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights
02/08/2018
EXTON, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]
Selecta Biosciences to Present at the Canaccord Growth Conference on August 9, 2018
02/08/2018
WATERTOWN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Opiant Pharmaceuticals to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on Thursday, August 9
02/08/2018
SANTA MONICA, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]

Pages